CBLL1 Antibody - BSA Free

Immunohistochemistry-Paraffin: CBLL1 Antibody [NBP1-83589]

Immunohistochemistry-Paraffin: CBLL1 Antibody [NBP1-83589] - Staining of human liver shows very weak positivity in hepatocytes as expected.

Immunohistochemistry-Paraffin: CBLL1 Antibody [NBP1-83589]

Immunohistochemistry-Paraffin: CBLL1 Antibody [NBP1-83589] - Staining of human placenta shows strong nuclear positivity in trophoblastic cells.

Western Blot: CBLL1 Antibody - BSA Free [NBP1-83589]

Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11
Lane 2: Human cell line RT-4

Western Blot: CBLL1 Antibody - BSA Free [NBP1-83589] -

METTL3, METTL14, WTAP and CBLL1 expression in non-malignant and prostate cancer cell lines; mRNA expression analysed by qRT-PCR relative to beta -actin(A–D) and protein expression analysed using western blot (E). METTL3 protein expression as previously reported in Haigh et al. (2022). *p ≤.05, **p ≤.005, ***p ≤.001, ****p ≤.0001 by unpaired t-test. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36733939), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: CBLL1 Antibody - BSA Free [NBP1-83589] -

METTL3, METTL14, WTAP and CBLL1 expression in PCa cell lines LNCaP (n = 9) (A), LNCaP:C4-2 (n = 9) (B), 22Rv1 (n = 6) (C) with vehicle or R1881 (1 nM) treatment for 72 h; mRNA expression analysed by qRT-PCR relative to beta -actin and protein expression analysed using western blot (D). ns, not significant; **p ≤.005, ***p ≤.001, ****p ≤.0001 by unpaired t-test. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36733939), licensed under a CC-BY license. Not internally tested by Novus Biologicals.